781 related articles for article (PubMed ID: 11705127)
1. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
[TBL] [Abstract][Full Text] [Related]
2. Treatment cost of acute exacerbations of chronic bronchitis.
Niederman MS; McCombs JS; Unger AN; Kumar A; Popovian R
Clin Ther; 1999 Mar; 21(3):576-91. PubMed ID: 10321424
[TBL] [Abstract][Full Text] [Related]
3. The costs of epilepsy misdiagnosis in England and Wales.
Juarez-Garcia A; Stokes T; Shaw B; Camosso-Stefinovic J; Baker R
Seizure; 2006 Dec; 15(8):598-605. PubMed ID: 17011217
[TBL] [Abstract][Full Text] [Related]
4. Estimating the cost of smoking to the NHS in England and the impact of declining prevalence.
Callum C; Boyle S; Sandford A
Health Econ Policy Law; 2011 Oct; 6(4):489-508. PubMed ID: 20735898
[TBL] [Abstract][Full Text] [Related]
5. Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK.
Brown RE; Breugelmans JG; Theodoratou D; Bénard S
Curr Med Res Opin; 2006 Apr; 22(4):663-70. PubMed ID: 16684427
[TBL] [Abstract][Full Text] [Related]
6. Annual cost of bipolar disorder to UK society.
Das Gupta R; Guest JF
Br J Psychiatry; 2002 Mar; 180():227-33. PubMed ID: 11872515
[TBL] [Abstract][Full Text] [Related]
7. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema.
Wilson L; Devine EB; So K
Respir Med; 2000 Mar; 94(3):204-13. PubMed ID: 10783930
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of chronic obstructive pulmonary disease.
Teo WS; Tan WS; Chong WF; Abisheganaden J; Lew YJ; Lim TK; Heng BH
Respirology; 2012 Jan; 17(1):120-6. PubMed ID: 21954985
[TBL] [Abstract][Full Text] [Related]
9. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
10. Economic implications of multiple births: inpatient hospital costs in the first 5 years of life.
Henderson J; Hockley C; Petrou S; Goldacre M; Davidson L
Arch Dis Child Fetal Neonatal Ed; 2004 Nov; 89(6):F542-5. PubMed ID: 15499151
[TBL] [Abstract][Full Text] [Related]
11. Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial.
Williams NH; Edwards RT; Linck P; Muntz R; Hibbs R; Wilkinson C; Russell I; Russell D; Hounsome B
Fam Pract; 2004 Dec; 21(6):643-50. PubMed ID: 15531626
[TBL] [Abstract][Full Text] [Related]
12. The cost of treating osteoporotic fractures in the United Kingdom female population.
Dolan P; Torgerson DJ
Osteoporos Int; 1998; 8(6):611-7. PubMed ID: 10326069
[TBL] [Abstract][Full Text] [Related]
13. Annual cost of erectile dysfunction to UK Society.
Plumb JM; Guest JF
Pharmacoeconomics; 1999 Dec; 16(6):699-709. PubMed ID: 10724796
[TBL] [Abstract][Full Text] [Related]
14. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of a general practitioner with special interests led dermatology service in primary care.
Coast J; Noble S; Noble A; Horrocks S; Asim O; Peters TJ; Salisbury C
BMJ; 2005 Dec; 331(7530):1444-9. PubMed ID: 16339217
[TBL] [Abstract][Full Text] [Related]
16. Cost of schizophrenia in England.
Mangalore R; Knapp M
J Ment Health Policy Econ; 2007 Mar; 10(1):23-41. PubMed ID: 17417045
[TBL] [Abstract][Full Text] [Related]
17. Direct healthcare costs and predictors of costs in patients with primary Sjogren's syndrome.
Callaghan R; Prabu A; Allan RB; Clarke AE; Sutcliffe N; Pierre YS; Gordon C; Bowman SJ;
Rheumatology (Oxford); 2007 Jan; 46(1):105-11. PubMed ID: 16728437
[TBL] [Abstract][Full Text] [Related]
18. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK.
Stewart S; Murphy NF; Walker A; McGuire A; McMurray JJ
Heart; 2004 Mar; 90(3):286-92. PubMed ID: 14966048
[TBL] [Abstract][Full Text] [Related]
19. Cost of schizophrenia to UK Society. An incidence-based cost-of-illness model for the first 5 years following diagnosis.
Guest JF; Cookson RF
Pharmacoeconomics; 1999 Jun; 15(6):597-610. PubMed ID: 10538332
[TBL] [Abstract][Full Text] [Related]
20. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
Fidan D; Unal B; Critchley J; Capewell S
QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
